Roth Capital lowered the firm's price target on Joint Corp. to $12 from $14 and keeps a Buy rating on the shares. The company's Q4 results exceeded estimates while its 2026 guidance largely mirrors the firm's model, the analyst tells investors in a research note. Roth adds, however, that the management's post-refranchising pro forma model is "underwhelming", even though it continues to see significant long-term upside.
